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Abstract
Purpose: To develop ampicillin-loaded chitosan nanoparticles by modified ionic gelation 
method for evaluating their antimicrobial activity onto Escherichia coli.
Methods: Ampicillin-loaded chitosan nanoparticles (CHT-NPs) prepared by ionic gela-
tion method with sodium tripolyphosphate as cross-linking agent. Drug release param-
eters (zeta potential, particle size, entrapment efficiency, and in vitro drug release) were 
assessed in relation to CHT-NP antimicrobial profile on E. coli. Antibacterial properties 
of CHT-NP formulation with ampicillin were found better than mere ampicillin without 
CHT-NPs.
Results: SEM, AFM images revealed dimensions of CHT-NPs with irregularity in shape/
size. Optimized concentrations of chitosan 0.5% w/v with three different ratios (0.05% to 
0.3% w/v) of TPP proved optimal for the evaluation of antibacterial profile of CHT-NPs. 
In vitro ampicillin-loaded CHT-NP delivery studies revealed an initial burst followed by 
slow sustained drug release, demonstrating superior antimicrobial activity than plain 
ampicillin, due to the synergistic effect of chitosan and ampicillin.
Conclusion: Chitosan content and cross-linking agent concentrations are control factors 
in synthesis of the optimized CHT-NP formulation. CHT-NPs with ampicillin cargo capa-
bly sustained ampicillin delivery due to NP size and increased surface charge, resulting 
in efficient growth inhibition in assays with E. coli.
Keywords: ampicillin, chitosan nanoparticles, drug delivery, Escherichia coli,  
ionic gelation
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1. Introduction
Drug delivery systems are effective for implementing sustained release of many kinds of 
drugs. Chitosan (CHT), in particular chitosan nanoparticles (CHT-NPs), have been fre-
quently used in drug delivery applications [1]. CHT is the generic name for a family of 
strongly polycationic derivatives of poly-N-acetyl-D-glucosamine (chitin) found in the exo-
skeletons of crustaceans such as crabs and shrimps. It can also be found in the cell wall of 
fungi and bacteria. Structurally, it is a linear polymer of cationic character formed by units 
of 2-amino-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-glucose linked by 1–4 bonds [2]. 
Having a positive charge, CHT is ideal for many drug delivery applications [3, 4]. CHT is 
biodegradable, non-toxic, non-immunogenic and biocompatible as well as the only natu-
rally occurring polycationic polymer. Along with its derivatives, CHT has received a great 
deal of attention from the pharmaceutical industry as antimicrobial and antifungal agent 
[3, 4]. An extensive review of biocompatibility, hydrophilicity, biodegradability and broad 
spectrum gram-negative/positive antibacterial and anti-fungal effects of chitosan can be 
found [2].
CHT-NPs exhibit great drug encapsulation efficiency (EE) and diverse release profiles, ade-
quate for transporting different types of drugs in many environments [5]. By controlling 
synthesis parameters conveniently (i.e. reagent concentrations, stirring speed), their diam-
eter, surface charge and other properties can be easily modified thereby leading to a versatile 
delivery vehicle. CHT-NPs can be synthesized using the ion gelation method with tripoly-
phosphate (TPP) as cross-linking agent [6, 7]. Ionic cross-linking of CHT is a typical non-cova-
lent interaction, which can be realized by association with negatively charged multivalent 
ions of TPP. There is a considerable body of literature on the production of CHT-TPP using 
this method, with many variations concerning the concentrations and ratios of the initial com-
ponents, of which [1, 7] are seminal works in these matter. Ion gelation allows encapsulation 
of various compounds, including β-lactams.
Ampicillin is a beta-lactam antibiotic with amino-penicillin skeleton that easily penetrates 
outer membrane gram-positive/negative bacteria and irreversibly inhibits the transpep-
tidase enzyme—needed for synthesis of the bacterial cell wall [8]—in the third and final 
stage of synthesis in binary fission leading cell lysis (bacteriolytic) [9]. Bacterial resistance to 
antibiotics, including ampicillin, has been observed and investigated for three decades as a 
serious threat and health crisis [10]. Several mechanisms have been found liking transpepti-
dase synthesis and activation pathways to bacterial resistance to ampicillin in E. coli. Given 
that ampicillin drug acts as a broad-spectrum penicillin/antibiotic in treatment of infections 
caused by gram-positive/negative bacteria, and the broad-spectrum β-lactamases among 
Enterobacteriaceae [11] that is evolutionary conserved, finding novel synergistic ways to curb 
such general and versatile resistance mechanisms is essential for ensuring continued effec-
tiveness of antimicrobial agents [12].
In this work, ampicillin-loaded CHT-NPs were synthesized and the effectiveness of their anti-
microbial activity was evaluated against ampicillin and CHT-NPs on E. coli. A set of synthe-
sis conditions was investigated in terms of their effect upon particle size, morphology and 
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surface charge. After selection of the most viable delivery system from the later analysis, the 
β-lactamic antibiotic (ampicillin) was encapsulated in order to evaluate the encapsulation effi-
ciency of the CHT-NPs. A release profile was obtained in order to assess their applicability 
as antimicrobial agents against gram-negative bacteria. The aim of the present study is the 
development of a simple method of synthesis of nano-carriers capable of transporting and 
releasing a drug such as ampicillin, ultimately inhibiting growth on E. coli.
2. Materials and methods
2.1. Reagents
CHT with molecular weight between 100,000 and 300,000 (ACROS Organics™), sodium tri-
polyphosphate and glacial acetic acid were used. Ultra-pure water was obtained using the 
Milli-Q A10 system (Millipore). Ampicillin sodium salt (Fisher BioReagents) was used as the 
antimicrobial agent.
2.2. Bacterial strain
E. coli ATCC 25922 was used for this study.
2.3. Synthesis of chitosan nanoparticles
CHT-NPs were produced using a modified ion gelation method. Briefly, CHT was dissolved 
at 0.5% w/v in 2% v/v acid acetic solution. Sodium tripolyphosphate was dissolved in ultra-
pure water to obtain a 0.1% w/v concentration. An ampicillin volume of 1 ml was then added 
and later 1 ml of the TPP solution was added drop-wise to 1.5 ml of the CHT solution and 
magnetically stirred for 1 h. The final suspension was centrifuged at 11,000 rpm for 20 min [6, 
13]. Three concentrations of CHT (0.1, 0.3 and 0.5% w/v) and five concentrations of TPP (0.005, 
0.01, 0.05, 0.1 and 0.3% w/v) were employed in order to determine their optimal ratio in terms 
of particle size and surface charge.
2.4. Statistical analysis
In order to evaluate the role of synthesis parameters on particle size and surface charge, 
including random variations in CHT and then TPP concentrations, selection of linear 
mixed effects models was performed using standard the Akaike information criterion 
(AIC), the Bayes information criterion (BIC) and the negative 2 log likelihood criterion 
(−2LL) [14]. The generalized form ( Ω 
0
 2 ) of the usual coefficient of determination (R
2
) was 
used [15]. A total of five models (including interactions) were evaluated for each response 
variable, that is, particle size and ζ potential. Calculations were performed using the R 
Statistical Computing package [16] with the lmer4 package for linear mixed effects models 
[17]. The Staterthwaite approximation of p values was computed for the corresponding 
observable (Table 1) [18].
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2.5. Determination of particle size and ζ potential
The determination of particle size (apparent hydrodynamic diameter) was performed by 
dynamic light scattering (DLS) and surface electric charge using a Zetasizer Malvern Nano 
SZ-90 particle analyser, reported as either ζ potential or electrophoretic mobility [7].
2.6. Morphology analysis of CHT-NPs
In order to study the morphology of nanoparticles, topographic images of CHT-NPs were 
taken on a multi- mode atomic force microscope (AFM) Asylum Research MFP-3D. The AFM 
probes used for this study were rectangular silicon probes with a nominal spring constant of 
40 nN/nm. Similarly, image visualization was carried out in a scanning electron microscope 
(SEM) Hitachi S-3700 with a 15 nm gold coating on the diluted samples (1/10) using an alumi-
num base at an acceleration voltage of 15 kV [7].
2.7. Determination of encapsulation efficiency of loaded CHT-NPs
The encapsulation efficiency (EE) of the CHT-NPs was determined according to the method 
described in the previous studies [19]. In brief, the nanoparticle suspensions were separated 
by centrifuging at 11,000 rpm for 20 min and the contents of ampicillin in the supernatants 
were measured by HPLC-DAD Perkim Elmer. A blank sample of CHT-NPs without ampicil-
lin was obtained but treated similarly as the drug-loaded CHT-NPs. All samples were mea-
sured in triplicate. The EE were calculated using.
  EE =  F __
T
× 100% (1)
where F is the free amount of ampicillin in the supernatant, T is total amount of ampicillin.
Model Response variable Fixed effects
1 Size 1
2 Size CHT concentration
3 Size TPP concentration
4 Size CHT + TPP concentrations
5 Size CHT + TPP + CHT*TPP concentrations
6 ζ potential 1
7 ζ potential CHT concentration
8 ζ potential TPP concentration
9 ζ potential CHT + TPP concentrations
10 ζ potential CHT + TPP + CHT*TPP concentrations
The value of 1 in effects represents the case of a purely random model used as the baseline.
Table 1. Statistical models for evaluating formulations.
Chitin-Chitosan - Myriad Functionalities in Science and Technology248
2.8. Release profile of loaded CHT-NP
Release studies were carried out in PBS (pH 7.4) as follows: 1.5 ml ampicillin-loaded CHT-
NPs and 1.5 ml PBS were incubated at 37°C and shaken at 200 rpm. Triplicate samples were 
analyzed at each time step, between 0 and 24 h. The samples were centrifuged and the concen-
trations of ampicillin released in the supernatant were determined by HPLC-DAD.
2.9. Determination of antimicrobial activity of loaded CHT-NPs
The spectrophotometrically adjusted inoculum (100 μl) of 104 bacterial cells was added to 
each well in the sterile flat-bottomed microtiter plate containing the test CHT-NPs. The 
design of experiments includes duplicated wells of ampicillin-loaded nanoparticles with 
three different concentrations of ampicillin (5, 10, 20 mg/ml), two wells with ampicillin 
as growth inhibition control, two wells containing bacterial suspension with CHT-NPs 
(growth control) and two wells containing only media (background control) were included 
in this plate. For the case of wells with ampicillin and CHT-NPs, dilutions were halved at 
each consecutive level in the gradient. Optical densities were measured for 24 h at 37°C 
using a multi-detection microplate reader Biotek Synergy HT at 600 nm and automatically 
recorded for each well every 30 min. Turbidimetric growth curves were obtained depending 
on the changes in the optical density of bacterial growth for each CHT NP sample and the 
drug-free growth control.
3. Results and discussion
3.1. Particle size and surface charge of loaded CHT-NPs
Figure 1 corresponds to measures of nanoparticle size (a) and ζ potential (b) according to 
the concentrations indicated above for both CHT and TPP. As TPP concentration increases, 
diameter decreases at 0.3 and 0.5% w/v CHT concentrations (a). The opposite occurs at a CHT 
concentration of 0.1% w/v. In the case of ζ potential (b), all CHT concentrations yield decreas-
ing values as TPP concentration increases.
Statistical models revealed that the best alternative for explaining nanoparticle size in terms 
of CHT and TPP concentrations is model 5, which includes both factors as well as their inter-
action (Table 2). Both AIC and −2LL have a larger distance from the baseline than in model 3 
(size only depending on TPP concentration), being also more significant and with a better fit 
than it. Figure 1(a) shows that nanoparticle size decreases as TPP concentration increases and, 
simultaneously, CHT concentration decreases. In that sense, model 5 also indicates that while 
TPP is the largest driver of nanoparticles diameter (χ2 = 3.536, df = 4, p(χ2) < 0.001), the interac-
tion between CHT and TPP is responsible for the observed change in slope (dotted lines for 
each line). CHT concentration seems not to have a large role by itself.
A similar analysis was carried out for ζ potential (Figure 1(b)). By the same criteria, model 10 
was the best criteria for all AIC, BIC and −2LL simultaneously. While all factors are statisti-
cally significant, TPP concentration.
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central (χ2 = 6604.98, df = 4, p(χ2) < 0.001): as it increases, ζ potential decreases thanks to a lower 
amount of available binding sites in the CHT matrix (Table 3).
Finally, the most significant levels for both size (diameter in nm) and ζ potential that include CHT 
and TPP concentrations were identified (p < 0.001) as candidates (Table 4). In agreement with 
existing literature, nanoparticles with a large ζ potential (ζ ≥ 40 mV) are desirable due to their 
good stability [20, 21] having sizes in between 200 and 580 nm [5, 22] for the particular case of 
CHT-NPs. From Figure 2, it is clear that levels 1 and 2 reported in Table 4 (matching Samples M 
and N in Table 5) comply with these requirements. The choice of sample N maximizes the value 
for the ζ potential while preserving a small nanoparticle size within the range mentioned above.
3.2. Morphology analysis of loaded CHT-NPs
A batch of CHT-NPs without cargo was synthesized and visualized using AFM imaging accord-
ing to sample preparation N (Figure 3). Scan areas are (A) 5 μm × 5 μm and (B) 1 μm × 1 μm 
respectively for 3A and 3B. The distribution of nanoparticle diameters is reported in Figure 4 
after post-processing of the AFM image.
Figure 1. Nanoparticle diameter (nm) and ζ potential (mV) at different concentrations of CHT and TPP. CHT 
concentration has a marked inverse effect to that of TPP on nanoparticle size, evidence of interference between both 
factors. A similar trend is identifiable for ζ potential between the lowest and highest TPP concentrations. (a) Nanoparticle 
diameter. (b) ζ potential.
Model df AIC BIC −2LL χ2 df (χ2) p(χ2)  Ω 
0
 2 
2 6 597.35 608.19 −292.67 0.206 2 0.902 0.853
3 8 590.54 604.99 −287.27 10.805 2 0.005* 0.844
4 10 594.11 612.17 −287.05 0.433 2 0.805 0.843
5 18 566.67 599.19 −265.33 43.440 8 <0.001* 0.852
Model 1 is not included (comparison baseline). *Significant p values.
Table 2. Results for selection of linear mixed effects models using maximum likelihood for nanoparticles size as the 
response variable.
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Additionally, SEM images were performed upon samples with and without ampicillin cargo 
(Figure 5). Images 5A, 5B and 5C are from a CHT-NPs sample. It verifies that CHT-NPs have 
a dispersed, corrugated and spherical morphology with a diameter between 100 and 200 nm. 
Complementary, images 5D, 5E and 5F belong to 10 mg/ml ampicillin-loaded CHT-NPs 
sample with an EE more than 40% (Figure 6) these samples have a smooth spherical mor-
phology with a diameter between 500 and 1000 nm, showing an aggregation effect between 
nanoparticles.
3.3. Encapsulation efficiency of loaded CHT-NPs
For encapsulation efficiency (Figure 6) the initial ampicillin concentration was compared against 
final encapsulated concentration (Figure 6(a)) and later transformed into EE (Figure 6(b)). EE 
lies within a range of 15–41% with a peak value at a concentration of ampicillin of 4 mg/ml in 
the final CHT-NPs solution volume.
3.4. Release profile of loaded CHT-NP
A release profile was obtained for the ampicillin-loaded CHT-NPs (Figure 7). Released per-
centage was calculated in relation to the encapsulated ampicillin concentration. Release 
percentage oscillates between 5 and 20% across 24 h. The burst effect is clearly observable 
(between 0 and 2 h), to be later succeeded by a more stable behavior (from 2 to 18 h) and ris-
ing finally in the last stage (from 18 to 24 h). The observed pattern suggests that swelling of 
the first layer in the polymeric matrix releases a large amount of ampicillin in the medium 
(0–1 h), and becomes more stable until the innermost layers are reached, where the remaining 
Model df AIC BIC −2LL χ2 df (χ2) p(χ2)  Ω 
0
 2 
7 6 278.95 289.79 −133.477 0.862 2 0.650 0.995
8 8 261.73 276.18 −122.866 21.222 2 <0.001* 0.995
9 10 261.64 279.71 −120.822 4.087 2 0.13 0.995
10 18 196.41 228.93 −80.204 81.2370 8 <0.001* 0.995
Model 6 is not included (comparison baseline). *Significant p values.
Table 3. Results for selection of linear mixed effects models using maximum likelihood for ζ potential as the response 
variable.
Level Concentrations
1 CHT 0.5%w/v, TPP 0.05%w/v
2 CHT 0.5%w/v, TPP 0.1%w/v
3 CHT 0.5%w/v, TPP 0.3%w/v
Only levels with p < 0.001 are shown here.
Table 4. Significant levels for CHT and TPP concentrations simultaneously reported in model 5 for nanoparticle size and 
model 10 for ζ potential.
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Figure 2. Scatter plot for diameter and surface charge of different CHT-NPs. The classification (clusters) was computed 
using the Hartigan-Wong k-means clustering algorithm [23]. Formulations indicate both CHT and TPP concentrations 
used for each nanoparticle type. The top left points in the green cluster (above 45 mV and below 300 nm) are the best 
delivery targets with respect to size and ζ potential, which appear at medium to low concentrations of TPP (0.05–0.1% 
w/v) and mostly at medium and high concentrations of CHT (except for C with 0.1% w/v). Most experimentally found 
diameters are below 600 nm. In the case of surface charge, data are partitioned in two groups: above 40 mV and below 
20 mV with no nanoparticle in the middle.
Sample CHT TPP d ζ
A 0.1 0.005 323.57 ± 186.84 60.23 ± 2.85
B 0.1 0.01 565.60 ± 97.49 59.67 ± 0.92
C 0.1 0.05 133.60 ± 18.34 48.37 ± 0.31
D 0.1 0.1 347.43 ± 17.60 10.73 ± 0.59
E 0.1 0.3 492.63 ± 16.35 2.92 ± 0.16
F 0.3 0.005 331.73 ± 168.06 57.17 ± 2.28
G 0.3 0.01 562.73 ± 155.08 57.33 ± 2.06
H 0.3 0.05 241.90 ± 34.51 47.30 ± 0.53
I 0.3 0.1 239.30 ± 27.14 51.73 ± 1.25
J 0.3 0.3 214.93 ± 11.40 9.53 ± 0.40
K 0.5 0.005 906.97 ± 264.60 54.63 ± 2.26
L 0.5 0.01 498.30 ± 49.73 56.27 ± 0.95
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Figure 3. AFM image of CHT-NPs without ampicillin cargo. AFM images were performed as a first assessment of 
CHT-NP synthesis process. Figure 5 provides the contrast between these nanoparticles and ampicillin loaded CHT-NPs. 
A corresponds to a scan area of 5 μm × 5 μm and B to 1 μm × 1 μm.
Sample CHT TPP d ζ
M 0.5 0.05 90.88 ± 30.90 52.63 ± 2.53
N 0.5 0.1 213.50 ± 29.76 53.73 ± 3.33
O 0.5 0.3 130.56 ± 15.65 20.03 ± 1.46
CHT and TPP concentrations are given in terms of w/v percentage. Diameter d is given in nm. ζ potential is given in 
mV. Standard deviation is included in both cases.
Table 5. CHT and TPP concentrations for synthesis of nanoparticles in Figure 2.
Figure 4. Histogram of CHT-NPs diameters for the AFM image in Figure 3. N = 632, d¯ = 80.5 nm, σ
d
 = 55.6 nm.
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contents are finally released. The latter is consistent with what is described by Carbinato et al. 
[24] for cross-linked pectin/high-amylose starch matrices.
3.5. Growth inhibition assays for E. coli ATCC 25922
Figure 8 shows the growth inhibition assays for E. coli ATCC 25922, an ampicillin−susceptible 
reference strain. Under the conditions of this assay, this strain shows a minimal inhibitory 
Figure 5. SEM image of CHT-NPs, without and with antibiotic cargo (ampicillin). A, B and C are images of nanoparticles 
without cargo and D, E and F encapsulate ampicillin. Nanoparticle diameter and size appears to increase in order to gain 
stability in ampicillin-loaded nanoparticles, which also has an additional aggregation effect.
Figure 6. Cargo efficiency of the CHT-NPs from initial concentrations, obtained as described in [19]. (a) Measured 
encapsulated ampicillin concentration through HPLC. (b) Corresponding encapsulation efficiency, calculated as EE in 
Eq. (1).
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concentration (MIC) of 2 μg/ml, which is in agreement with the range values (2–8 μg/ml) previously 
reported [25]. A clinical E. coli isolate is considered as non-susceptible when its MIC value is >8 μg/ml. 
The highest ampicillin concentration used as control was 500 μg/ml (dilution 1, Figure 8), generat-
ing a concentration gradient by double dilutions through 3.91 μg/ml (dilution 8, Figure 8). The 
three ampicillin-loaded CHT-NPs systems (C, D and E) show a similar growth inhibition pattern 
with respect to the positive control (ampicillin), indicating that under these conditions ampicillin 
is released from CHT − NPs to concentrations high enough to inhibit bacterial growth. Moreover, 
both CHT − NPs systems D and E, loaded with 10 mg/ml and 20 mg/ml of ampicillin respectively, 
maintain growth inhibition with more dilutions with respect to ampicillin. It is worth noting that 
inhibition in samples A and C lower their effectiveness rapidly after the fifth dilution, but samples 
D and E have a much wider range of inhibition at lower concentrations for all remaining dilutions.
Figure 7. Release profile of ampicillin-loaded CHT-NPs. A burst effect was observed for the first hour, followed by a 
stabilization phase (1–4 h), a steady release phase (4–15 h) and posterior relative increase (15–24 h).
Figure 8. Growth inhibition assays for E. coli. Samples are as follows: (A) ampicillin 20 mg/ml, (B) CHT-NPs, ampicillin-
loaded NPs at (C) 5 mg/ml, (D) 10 mg/ml and (E) 20 mg/ml. As expected, sample B produces no inhibition, while A–C 
remain effective until the fifth dilution and D–E to the sixth dilution.
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4. Conclusions
CHT-NPs synthesis was successfully achieved and the manipulation of CHT and TPP 
concentrations towards optimization for drug delivery resulted in smaller particles and 
increased surface charge. Besides, a detailed physicochemical characterization of CHT-
NPs was obtained. CHT-NPs were able to encapsulate and release ampicillin. The encapsu-
lation efficiency of ampicillin CHT-NPs exceeds 30% in most cases while antibiotic release 
maintains a relatively stable profile, ranging between 5 and 20% in a 24-hour period. 
A microbiological assay was used as proof of principle in order to verify the release of 
the antibiotic ampicillin from the CHT-NPs systems. Growth inhibition of the ampicillin-
susceptible E. coli ATCC 25922 reference strain was achieved in a similar pattern compared 
with ampicillin alone.
In terms of the obtained release profile in a period of 24 h, several comparisons can be drawn 
in terms of other alternatives. The cumulative release profile, computed from data shown in 
Figure 7, indicates that less than 40% of the cargo was released after 24 h. Ampicillin-loaded 
electrospun poly(ε-caprolactone) nanofiber yarns have a much faster release profile, releasing 
more than 90% of its cargo in the same period [26]. By contrast, our formulation has a release 
profile faster than that reported for ampicillin-conjugated gum Arabic microspheres [27]. 
In the later cases, no additional antibiotic or bacteriostatic effect is present in the polymeric 
matrix. CHT-NPs loaded with ampicillin reported here are comparable to chitosan micro-
granules loaded with diclofenac sodium in contrast to chitosan beads loaded with diclof-
enac sodium in terms of the order of magnitude of released antibiotic [28]. Compared against 
ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres, our nanoparti-
cles have a significantly lower encapsulation efficiency [29], yet the former are not suitable for 
sustained release. CHT-NPs are similar in size compared to existing literature on ampicillin-
loaded nanoparticles and liposomes [30], with a release profile closer to that of liposomes. In 
the later study, liposomes had a larger inhibition halo at lower dilutions than nanoparticles of 
higher density and longer release time.
Finally, the synthesis protocol of CHT-NPs elaborated in this study constitutes a platform for 
the analysis of the encapsulation of other antibiotics with different structures as well as for 
assays on other bacteria.
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